Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 196,576 | 213,808 | 220,382 | 167,413 | 217,127 |
| Cost of Goods | 9,493 | 12,731 | 14,144 | 10,893 | 14,011 |
| Gross Profit | 187,083 | 201,077 | 206,238 | 156,520 | 203,116 |
| Operating Expenses | 305,740 | 411,351 | 323,997 | 357,751 | 271,314 |
| Operating Income | -118,164 | -209,543 | -117,615 | -200,338 | -68,187 |
| Interest Expense | 28,160 | 29,415 | 27,331 | 24,501 | 20,880 |
| Other Income | -20,266 | 1,479 | 9,956 | 35,146 | -38,141 |
| Pre-tax Income | -166,590 | -237,479 | -134,990 | -189,693 | -127,208 |
| Income Tax | -33,620 | -38,596 | 3,969 | -18,804 | -17,893 |
| Net Income Continuous | -132,970 | -198,883 | -138,959 | -170,889 | -109,315 |
| Net Income | $-132,970 | $-198,883 | $-138,959 | $-170,889 | $-109,315 |
| EPS Basic Total Ops | -1.76 | -2.66 | -1.88 | -2.35 | -1.53 |
| EPS Basic Continuous Ops | -1.76 | -2.66 | -1.88 | -2.36 | -1.53 |
| EPS Diluted Total Ops | -1.76 | -2.66 | -1.88 | -2.35 | -1.53 |
| EPS Diluted Continuous Ops | -1.76 | -2.66 | -1.88 | -2.36 | -1.53 |
| EBITDA(a) | $-55,537 | $59,822 | $-74,437 | $-127,583 | $-33,077 |